Poolbeg Pharma PLC (POLBF)
OTCMKTS
· Delayed Price · Currency is USD
0.1180
-0.0330 (-21.85%)
At close: Nov 7, 2024
Poolbeg Pharma Employees
Poolbeg Pharma had 15 employees as of December 31, 2023. The number of employees increased by 3 or 25.00% compared to the previous year.
Employees
15
Change (1Y)
3
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$368,859
Market Cap
18.92M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 15 | 3 | 25.00% |
Dec 31, 2022 | 12 | 5 | 71.43% |
Dec 31, 2021 | 7 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
CytoDyn | 9 |
Glass House Brands | 374 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 116 |
American Oncology Network | 1,914 |
Poolbeg Pharma News
- 2 months ago - FTSE 100 ends flat as US data dampens sentiment - Investomania
- 2 months ago - UK Stock Market News: Standard Chartered, Poolbeg Pharma, UK Oil & Gas - The Armchair Trader
- 4 months ago - AIM Market Roundup: Immupharma, Poolbeg, Xeros - The Armchair Trader
- 4 months ago - AIM Market round-up: Team Internet, Verici, Poolbeg Pharma - The Armchair Trader
- 4 months ago - Cathal Friels Poolbeg Pharma plunges on merger talks that would see listing move to Nasdaq - Independent Ireland
- 4 months ago - Cathal Friels Poolbeg Pharma in merger talks that could land Nasdaq listing - Independent Ireland
- 10 months ago - Poolbeg Pharma PLC Announces Voluntary Delisting from OTCQB Market - Accesswire
- 11 months ago - Poolbeg Pharma PLC Announces Notification of Major Holdings - Accesswire